Mazelsky Jonathan Jay reported option exercise involving 25,140 shares of IDEXX LABORATORIES INC DE at $178.26 for $4.48M on Nov 4, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Executive Chair of the Board
Executive Chair of the Board
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$4,481,456.40Shares × reported price
Shares traded
25,140Common Stock
Price per share
$178.26Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
108,943.302Direct
Trade date
Nov 4, 2026Option exercise
Filed
Nov 5, 2026, 5:01 PM ET1-day reporting delay
Accession
0000874716-26-000144Code M · Transaction 393701
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

IDXX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IDXX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −6.4%1w ago 0%1d ago 0%
Returns since7d +24%30d90d180d1y

Footnotes in full

F1: Represents the weighted average price of the shares sold ranging from a low of $697.80 to a high of $698.77 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F2: Represents the weighted average price of the shares sold ranging from a low of $698.92 to a high of $699.89 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F3: Represents the weighted average price of the shares sold ranging from a low of $700.00 to a high of $700.80 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F4: Represents the weighted average price of the shares sold ranging from a low of $701.005 to a high of $701.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F5: Represents the weighted average price of the shares sold ranging from a low of $702.00 to a high of $702.81 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F6: Represents the weighted average price of the shares sold ranging from a low of $703.04 to a high of $703.99 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F7: Represents the weighted average price of the shares sold ranging from a low of $706.60 to a high of $707.16 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F8: Represents the weighted average price of the shares sold ranging from a low of $707.645 to a high of $708.59 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F9: Represents the weighted average price of the shares sold ranging from a low of $708.65 to a high of $709.46 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F10: Represents the weighted average price of the shares sold ranging from a low of $709.815 to a high of $710.63 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F11: Represents the weighted average price of the shares sold ranging from a low of $710.82 to a high of $711.73 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F12: Represents the weighted average price of the shares sold ranging from a low of $711.845 to a high of $712.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F13: Grant of option to buy shares of Issuer common stock that vested in five annual installments beginning February 14, 2019. F14: Not applicable.